These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1641151)

  • 41. Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora's progressive myoclonic epilepsy.
    Singh S; Sethi I; Francheschetti S; Riggio C; Avanzini G; Yamakawa K; Delgado-Escueta AV; Ganesh S
    J Med Genet; 2006 Sep; 43(9):e48. PubMed ID: 16950819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Lafora disease complicating myoclonus epilepsy. Report of 3 cases].
    Testa G; Armani M; Giaretta D; Angelini C
    Riv Neurol; 1980; 50(5):338-49. PubMed ID: 6781057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy.
    Lalioti MD; Scott HS; Buresi C; Rossier C; Bottani A; Morris MA; Malafosse A; Antonarakis SE
    Nature; 1997 Apr; 386(6627):847-51. PubMed ID: 9126745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype.
    Ganesh S; Delgado-Escueta AV; Suzuki T; Francheschetti S; Riggio C; Avanzini G; Rabinowicz A; Bohlega S; Bailey J; Alonso ME; Rasmussen A; Thomson AE; Ochoa A; Prado AJ; Medina MT; Yamakawa K
    Hum Mol Genet; 2002 May; 11(11):1263-71. PubMed ID: 12019207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Familial progressive myoclonus epilepsy (Unverricht/Lundborg)].
    Herbst A
    Psychiatr Neurol Med Psychol Beih; 1967; 6():18-39. PubMed ID: 5006319
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of repetitive transcranial magnetic stimulation on action myoclonus: A pilot study in patients with EPM1.
    Rossi Sebastiano D; Magaudda A; Quartarone A; Brizzi T; Visani E; Capovilla G; Beccaria F; Anversa P; Franceschetti S; Canafoglia L
    Epilepsy Behav; 2018 Mar; 80():33-36. PubMed ID: 29396360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognitive functioning in progressive myoclonus epilepsy type 1 (Unverricht-Lundborg Disease, EPM1).
    Äikiä M; Hyppönen J; Mervaala E; Kälviäinen R
    Epilepsy Behav; 2021 Sep; 122():108157. PubMed ID: 34171687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [From gene to disease; progressive myoclonus epilepsy of Unverricht-Lundborg and mutations in the cystatin B gene].
    de Haan GJ; Halley DJ; Deelen WH; Lindhout D
    Ned Tijdschr Geneeskd; 2002 May; 146(18):846-8. PubMed ID: 12038222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progressive myoclonic ataxia without ragged red fibres: Unverricht-Lundborg disease vs Ramsay Hunt syndrome.
    Shakir RA; Khan RA; al-Zuhair AG
    Acta Neurol Scand; 1992 Nov; 86(5):470-3. PubMed ID: 1336290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lafora's disease. The role of skin biopsy.
    Newton GA; Sanchez RL; Swedo J; Smith EB
    Arch Dermatol; 1987 Dec; 123(12):1667-9. PubMed ID: 2825605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered cortical inhibition in Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1).
    Danner N; Julkunen P; Khyuppenen J; Hukkanen T; Könönen M; Säisänen L; Koskenkorva P; Vanninen R; Lehesjoki AE; Kälviäinen R; Mervaala E
    Epilepsy Res; 2009 Jul; 85(1):81-8. PubMed ID: 19321308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cortico-muscular coherence and brain networks in familial adult myoclonic epilepsy and progressive myoclonic epilepsy.
    Franceschetti S; Visani E; Panzica F; Coppola A; Striano P; Canafoglia L
    Clin Neurophysiol; 2023 Jul; 151():74-82. PubMed ID: 37216715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset.
    Lalioti MD; Scott HS; Genton P; Grid D; Ouazzani R; M'Rabet A; Ibrahim S; Gouider R; Dravet C; Chkili T; Bottani A; Buresi C; Malafosse A; Antonarakis SE
    Am J Hum Genet; 1998 Apr; 62(4):842-7. PubMed ID: 9529356
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A 405-kb cosmid contig and HindIII restriction map of the progressive myoclonus epilepsy type 1 (EPM1) candidate region in 21q22.3.
    Lafrenière RG; de Jong PJ; Rouleau GA
    Genomics; 1995 Sep; 29(1):288-90. PubMed ID: 8530089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Progressive myoclonic epilepsy secondary to Lafora's body disease].
    Potes T; Galicchio S; Rosso B; Besocke G; García MDC; Avalos JC
    Medicina (B Aires); 2018; 78(6):436-439. PubMed ID: 30504111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Myoclonic epilepsies in infancy].
    Palencia R
    Rev Neurol; 2000 Jun; 30 Suppl 1():S15-24. PubMed ID: 10904965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The minisatellite expansion mutation in EPM1: resolution of an initial discrepancy. Mutatations in brief no. 186. Online.
    Virtaneva K; Paulin L; Krahe R; de la Chapelle A; Lehesjoki AE
    Hum Mutat; 1998; 12(3):218. PubMed ID: 10660338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy.
    Minassian BA; Lee JR; Herbrick JA; Huizenga J; Soder S; Mungall AJ; Dunham I; Gardner R; Fong CY; Carpenter S; Jardim L; Satishchandra P; Andermann E; Snead OC; Lopes-Cendes I; Tsui LC; Delgado-Escueta AV; Rouleau GA; Scherer SW
    Nat Genet; 1998 Oct; 20(2):171-4. PubMed ID: 9771710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebellar Involvement in Patients with Mild to Moderate Myoclonus Due to EPM1: Structural and Functional MRI Findings in Comparison with Healthy Controls and Ataxic Patients.
    Nigri A; Visani E; Bertolino N; Nanetti L; Mariotti C; Panzeri M; Bruzzone MG; Franceschetti S; Canafoglia L
    Brain Topogr; 2017 May; 30(3):380-389. PubMed ID: 27785699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies.
    Kälviäinen R; Genton P; Andermann E; Andermann F; Magaudda A; Frucht SJ; Schlit AF; Gerard D; de la Loge C; von Rosenstiel P
    Epilepsia; 2016 Feb; 57(2):210-21. PubMed ID: 26666500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.